Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• Australia and New Zealand Dialysis and Transplant Registry The ANZATA RegistryMcDonald19 passages
• Biology of stem cells: an overview Biology of stem cellsChagastelles16 passages
• Biomarkers in kidney fibrosis: are they useful? Biomarkers in kidney fibrosisWong Muh Geot 1Pollock20 passages
• Calcimimetics and outcomes in CKD Calcimimetics and outcomes in CKDrüeke17 passages
• Cardiac and renal cell therapies: similarities and differences Cardiac and renal cell therapiesTakiya13 passages
• Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link? Cardiovascular and non-cardiovascular mortality in ESRDJager10 passages
• Fibrosis and renal aging Fibrosis and renal agingYang Hai-Chun 1Fogo12 passages
• Genetic tracing of the epithelial lineage during mammalian kidney repair Epithelial cells and kidney repairHumphreys10 passages
• Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients Hyperphosphatemia in CKDStreja Elani 18Lau Wei Ling 18Goldstein Leanne 1Sim23 passages
• KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of271 passages
• Key fibrogenic mediators: old players. Renin–angiotensin system21 passages
• Kick it up a notch: Notch signaling and kidney fibrosis Notch and kidney fibrosisSweetwyne24 passages
• Kidney Int Suppl (2011)4143 passages
• Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation19 passages
• Macrophage heterogeneity, phenotypes, and roles in renal fibrosis Macrophages in renal fibrosisCao Qi 1Wang Yiping 1Harris12 passages
• Macrophages promote renal fibrosis through direct and indirect mechanisms Mechanisms of macrophage-driven renal fibrosisNikolic-Paterson16 passages
• Major pathways of the reno–cardiovascular link: the sympathetic and renin–angiotensin systems The sympathetic system, RAS, and CKDBlankestijn16 passages
• Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks Mesenchymal stem cells in glomerular diseaseKunter Uta 1*Rong Song 1Moeller16 passages
• Mesenchymal stromal cells: main factor or helper in regenerative medicine? Mesenchymal stromal cells in organ repairZander10 passages
• Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation24 passages
• Overview of the cellular and molecular basis of kidney fibrosis Kidney fibrosis overviewEddy21 passages
• Platelet-derived growth factors (PDGFs) in glomerular and tubulointerstitial fibrosis PDGFs in renal fibrosisOstendorf Tammo 1*Boor Peter 123van Roeyen15 passages
• Primary proximal tubule injury leads to epithelial cell cycle arrest, fibrosis, vascular rarefaction, and glomerulosclerosis Tubule injury and cell cycle arrestBonventre21 passages
• Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials Treatment of AKI with mesenchymal stem cellsWestenfelder Christof 1*Togel12 passages
• Role of HIPK2 in kidney fibrosis HIPK2 and kidney fibrosisFan Ying 1Wang Niansong 1Chuang Peter 2He12 passages
• Role of SDF-1 as a regulatory chemokine in renal regeneration after acute kidney injury Stem cell homing post-AKITogel6 passages
• Searching novel diagnostic markers and targets for therapy of CKD Promising gene candidatesKavvadas Panos 1Dussaule Jean-Claude 1Chatziantoniou Christos 1*115 passages
• Stem cell therapy for diabetes mellitus Stem cell therapy for diabetesVoltarelli Júlio C 1*Couri17 passages
• The FOXD1 lineage of kidney perivascular cells and myofibroblasts: functions and responses to injury Homeostasis of peritubular capillariesGomez19 passages
• The complexity of the cardio–renal link: taxonomy, syndromes, and diseases Cardiovascular and renal medicine taxonomyZoccali Carmine 1*Goldsmith David 2Agarwal Rajiv 3Blankestijn13 passages
• The potential use of stem cells derived from human amniotic fluid in renal diseases Human amniotic fluid stem cells and the kidneyNoronha20 passages
• Tipping the balance from angiogenesis to fibrosis in CKD Capillary regression in renal fibrosisBallermann22 passages
• Toll-like receptor activation: from renal inflammation to fibrosis Role of Toll-like receptors in the kidneyYiu Wai Han 1Lin Miao 1Tang21 passages
• Training nephrologists from developing countries: does it have a positive impact? Fellowship for nephrologistsHarris15 passages
• Uremic osteoporosis Uremic osteoporosisKazama18 passages
• Vitamin D receptor activation: cardiovascular and renal implications17 passages
• What is the best way to measure renal fibrosis?: A pathologist's perspective Pathologic measurement of renal fibrosisFarris19 passages
• Wnt/β-catenin signaling and kidney fibrosis Wnt/β-catenin and kidney fibrosisTan25 passages